## Graphical summary of gag/gp41 sites at which amino acid mutations developed during therapy

### Gag sites

![Gag sites](https://github.com/hivdb/gag-gp41/raw/master/report/gag-mutations.png)

### Gp41 sites

![Gp41 sites](https://github.com/hivdb/gag-gp41/raw/master/report/gp41-mutations.png)

### Distribution figures for Naive Sequences

![Gag AA changes](https://github.com/hivdb/gag-gp41/raw/master/report/gag-naive-aachanges-dist.png)
![Gag stop codons](https://github.com/hivdb/gag-gp41/raw/master/report/gag-naive-stopcodons-dist.png)
![Gp41 AA changes](https://github.com/hivdb/gag-gp41/raw/master/report/gp41-naive-aachanges-dist.png)
![Gp41 stop codons](https://github.com/hivdb/gag-gp41/raw/master/report/gp41-naive-stopcodons-dist.png)

## Pairwise comparison

### gag

|                | PIs (24)         | NNRTIs (16)      | P value   |
|:---------------|:-----------------|:-----------------|:----------|
| NA differences |                  |                  |           |
| - All          | 1.1 (0.8-1.6%)   | 0.8 (0.5-1.3%)   | 0.16      |
| - MA           | 0.4 (0.2-0.6%)   | 0.2 (0.1-0.6%)   | 0.17      |
| - CTerminal    | 0.3 (0.2-0.7%)   | 0.3 (0.2-0.4%)   | 0.90      |
| AA differences |                  |                  |           |
| - All          | 1.4 (0.8-1.8%)   | 0.8 (0.6-1.4%)   | 0.21      |
| - MA           | 0.6 (0.4-0.6%)   | 0.4 (0.4-1.2%)   | 0.97      |
| - CTerminal    | 0.7 (0.2-1.0%)   | 0.6 (0.4-0.8%)   | 0.87      |
| dN/dS ratio    |                  |                  |           |
| - All          | 0.21 (0.08-0.48) | 0.35 (0.21-0.57) | 0.16      |
| - MA           | 0.24 (0.00-0.68) | 0.73 (0.18-inf)  | 0.16      |
| - CTerminal    | 0.46 (0.19-1.14) | 0.50 (0.23-0.99) | 0.89      |
| % Ambiguities  |                  |                  |           |
| Baseline       | 0.4 (0.1-0.8%)   | 0.1 (0.1-0.1%)   | 0.06      |
| Follow-up      | 0.0 (0.0-0.6%)   | 0.0 (0.0-0.1%)   | 0.18      |
| P value        | 0.02             | 0.02             | -         |

### gp41

|                | PIs (28)         | NNRTIs (17)      | P value   |
|:---------------|:-----------------|:-----------------|:----------|
| NA differences |                  |                  |           |
| - All          | 1.1 (0.5-1.5%)   | 0.8 (0.6-1.4%)   | 0.83      |
| - CD           | 0.4 (0.3-0.9%)   | 0.6 (0.2-0.7%)   | 1.00      |
| AA differences |                  |                  |           |
| - All          | 1.4 (0.6-2.2%)   | 1.3 (0.9-2.2%)   | 0.70      |
| - CD           | 0.9 (0.3-1.4%)   | 0.9 (0.6-1.1%)   | 0.85      |
| dN/dS ratio    |                  |                  |           |
| - All          | 0.42 (0.16-0.74) | 0.44 (0.29-0.96) | 0.43      |
| - CD           | 0.59 (0.17-1.99) | 0.47 (0.32-0.93) | 0.88      |
| % Ambiguities  |                  |                  |           |
| Baseline       | 0.1 (0.0-0.2%)   | 0.1 (0.0-0.1%)   | 0.81      |
| Follow-up      | 0.0 (0.0-0.1%)   | 0.0 (0.0-0.1%)   | 0.43      |
| P value        | 0.07             | 0.29             | -         |


## Gag cleavage sites

| Rx     | Cleavage site   | Position      | Baseline AAs   | Follow-up AAs   |   # patients |
|:-------|:----------------|:--------------|:---------------|:----------------|-------------:|
| PIs    | SP1/NC          | 373           | IPAAMMQRGN     | MPAAMMQRGN      |            1 |
| PIs    | SP1/NC          | 373           | PTAIMMQKGN     | STAIMMQKGN      |            1 |
| PIs    | SP1/NC          | 373, 375      | STAIMMQKGN     | PTTIMMQKGN      |            1 |
| PIs    | SP1/NC          | 374, 380      | PXAIMMQKGN     | PPAIMMQRGN      |            1 |
| PIs    | SP1/NC          | 374, 381      | SAAMMMQRSN     | STAMMMQRGN      |            1 |
| PIs    | SP1/NC          | 374           | SXAIMMQKGN     | STAIMMQKGN      |            1 |
| PIs    | SP1/NC          | 375, 378      | SANIMMQRGN     | SAAIMIQRGN      |            1 |
| PIs    | SP1/NC          | 376, 380      | SATIMMQKGN     | SATTMMQRGN      |            1 |
| PIs    | SP1/NC          | 378           | SASVMMQRGN     | SASVMIQRGN      |            1 |
| PIs    | NC/SP2          | 429, 436      | EKQANFLGRI     | ERQANFLGKI      |            1 |
| PIs    | NC/SP2          | 436           | ERQANFLGKL     | ERQANFLGRL      |            1 |
| PIs    | NC/SP2          | 436           | ERQANFLGXI     | ERQANFLGKI      |            1 |
| PIs    | NC/SP2          | 437           | ERQANFLGKX     | ERQANFLGKL      |            1 |
| PIs    | SP2/p6          | 453           | RPGNFLQSRL     | RPGNFLQSRP      |            2 |
| PIs    | p6/PR           | 485, 487, 490 | YSLTSLXSLF     | YPLASLKSLF      |            1 |
| PIs    | p6/PR           | 490           | YPLASLRSLF     | YPLASLKSLF      |            2 |
| NNRTIs | MA/CA           | 132           | VSHNYPIVQN     | VSHNFPIVQN      |            1 |
| NNRTIs | SP1/NC          | 373           | STAMMQ-RGN     | TTAMMQ-RGN      |            1 |
| NNRTIs | SP1/NC          | 374           | PTTIMMQRGN     | PATIMMQRGN      |            1 |
| NNRTIs | SP1/NC          | 375           | PAAIMMQRGN     | PATIMMQRGN      |            1 |
| NNRTIs | SP1/NC          | 375           | SAAIMMQKGN     | SANIMMQKGN      |            1 |
| NNRTIs | SP1/NC          | 375           | STAIMMQRGN     | STTIMMQRGN      |            1 |
| NNRTIs | NC/SP2          | 429           | EKQANFLGRL     | ERQANFLGRL      |            1 |
| NNRTIs | SP2/p6          | 453           | RPGNFPQSRL     | RPGNFPQSRP      |            1 |
| NNRTIs | p6/PR           | 484, 485      | NPL            | VSL             |            1 |
| NNRTIs | p6/PR           | 487           | YPLASLRSLF     | YPLTSLRSLF      |            1 |
| NNRTIs | p6/PR           | 490           | YPLASLKSLF     | YPLASLRSLF      |            1 |

## Positions with evidence for diversifying selection (FEL)

| Group         |   Position |   P value |
|:--------------|-----------:|----------:|
| gag - PIs     |         67 |    0.0384 |
| ~             |        115 |    0.0482 |
| ~             |        223 |    0.0052 |
| ~             |        468 |    0.0279 |
| ~             |        469 |    0.0077 |
| ~             |        474 |    0.0288 |
| gag - NNRTIs  |         54 |    0.0479 |
| ~             |         69 |    0.0384 |
| ~             |        116 |    0.03   |
| ~             |        173 |    0.049  |
| ~             |        375 |    0.0359 |
| ~             |        480 |    0.009  |
| ~             |        484 |    0.0138 |
| gp41 - PIs    |         55 |    0.0194 |
| ~             |        101 |    0.0131 |
| ~             |        273 |    0.0169 |
| gp41 - NNRTIs |         24 |    0.0088 |
| ~             |        187 |    0.0419 |
| ~             |        310 |    0.0417 |


## Positions with evidence for directional selection (MEDS)

| Group         | Mutation   | Detail   | # patients   |
|:--------------|:-----------|:---------|:-------------|
| gag - PIs     | 219H       | H=&gt;Q  | 1            |
| ~             | ~          | Q=&gt;H  | 3            |
| ~             | 370Y       | F=&gt;Y  | 1            |
| ~             | 371N       | T=&gt;N  | 1            |
| gag - NNRTIs  | 79F        | Y=&gt;F  | 2            |
| ~             | 110M       | K=&gt;M  | 1            |
| ~             | 116A/Q     | A=&gt;Q  | 1            |
| ~             | ~          | Q=&gt;A  | 1            |
| ~             | 371T       | A=&gt;T  | 1            |
| ~             | ~          | N=&gt;T  | 1            |
| ~             | 480L       | D=&gt;L  | 1            |
| gp41 - PIs    | 307I       | T=&gt;I  | 3            |
| ~             | 325F       | I=&gt;F  | 1            |
| ~             | ~          | L=&gt;F  | 1            |
| gp41 - NNRTIs | None       | -        | -            |

